Michael K. Schultz

Director Técnico/Científico/I+D en PERSPECTIVE THERAPEUTICS, INC. .

Commercial Services

Health Technology

Consumer Services

Perfil

Michael K.
Schultz founded Viewpoint Molecular Targeting, Inc. in 2008, where he is working as Chief Science Officer from 2013.
Dr. Schultz also currently works at Perspective Therapeutics, Inc., as Chief Science Officer.
Dr. Schultz also formerly worked at the University of Iowa, as Associate Professor and National Institute of Health Policy, as Principal.

Cargos activos de Michael K. Schultz

Empresas	Cargo	Inicio
PERSPECTIVE THERAPEUTICS, INC.	Director Técnico/Científico/I+D	-
Viewpoint Molecular Targeting, Inc. Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA.	Fundador	01/01/2008

Todos los cargos activos de Michael K. Schultz

Antiguos cargos conocidos de Michael K. Schultz.

Empresas	Cargo	Fin
National Institute of Health Policy	Corporate Officer/Principal	-
University of Iowa	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Michael K. Schultz.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michael K. Schultz.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
PERSPECTIVE THERAPEUTICS, INC.	Health Technology

Empresas privadas	2
Viewpoint Molecular Targeting, Inc. Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Viewpoint Molecular Targeting, Inc. develops pharmaceutical drugs for diagnostic imaging and therapy for cancer. The firm?s radiopharmaceutical drugs are designed to specifically localize in cancerous tissues in the human body. The company was founded by Frances L. Johnson, Michael K. Schultz and Heyward H. Coleman in 2008 and is headquartered in Coralville, IA.	Commercial Services
National Institute of Health Policy